Patients: HCC vs. (liver disease without HCC and healthy)Tests: serum GOLPH2 levels by ELISA, AFP not measured.Outcomes: sensitivity, specificity and cut off value were available, but AFP levels were not tested. This evidence concerns the gene GOLM1 and hepatocellular carcinoma.